About Resonacle Pharma Private Limited
Data last updated:
Resonacle Pharma Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 February 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74900MH2016PTC273571. Its GSTIN is 27AAHCR6497G1ZT (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jai Shree Panwar (Manager) and Greejesh Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No 503 B Wing 5th Floor Shelton Sapphire Plot No 18 & 19 Sector – 15 CBD Belapur, Navi Mumbai, Maharashtra, India – 410614.
As per the financials filed for FY 2024, the company reported a revenue of ₹53.73 Lakh. For the same year it recorded a net profit of ₹4.81 Lakh (net margin 9%) and EBITDA of ₹6.22 Lakh (EBITDA margin 11.6%). Revenue has grown at a compounded annual rate (CAGR) of 171% over five years.
The company is associated with 2 brands: Resonacle and Resonacle Pharma.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website resonaclepharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressOffice No 503 B Wing 5th Floor Shelton Sapphire Plot No 18 & 19 Sector – 15 CBD Belapur, Navi Mumbai, Maharashtra, India – 410614
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Resonacle Pharma Private Limited
The main business activity of Resonacle Pharma is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Resonacle Pharma Private Limited FY 2025 filings available
Resonacle Pharma Private Limited reported revenue of ₹53.73 Lakh for FY 2024.
Compounded Annual Growth Rate (CAGR) of Resonacle Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 171% over five years. EBITDA rose 216% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Resonacle Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹6.22 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.81 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Resonacle Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Resonacle Pharma are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Resonacle Pharma Private Limited
Resonacle Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sunbird Healthcare Private Limited | ₹54.09 Lakh (FY 2025) | •••• | •••• | -30.0% | •••• | Raipur, Chhattisgarh, India |
| Xellence Laboratories Private Limited | ₹54.07 Lakh (FY 2024) | •••• | •••• | -9.0% | •••• | New Delhi, Delhi, India |
| Miles Healthcare Private Limited | ₹54.03 Lakh (FY 2025) | •••• | •••• | -17.0% | •••• | Ahmedabad, Gujarat, India |
| Sanivo Biotec Private Limited | ₹53.76 Lakh (FY 2024) | •••• | •••• | -3.0% | •••• | South 24 Parganas, West Bengal, India |
| Hygieia Biogenics Private Limited | ₹53.74 Lakh (FY 2019) | •••• | •••• | 11.0% | •••• | Kolkata, West Bengal, India |
| Resonacle Pharma Private Limited this company | ₹53.73 Lakh (FY 2024) | •••• | •••• | •••• | Navi Mumbai, Maharashtra, India | |
| Bioplus Healthcare Private Limited | ₹53.5 Lakh (FY 2025) | •••• | •••• | 140.0% | •••• | Bangalore, Karnataka, India |
| Sanifia Biotech Private Limited | ₹53.5 Lakh (FY 2025) | •••• | •••• | 65.0% | •••• | Patna, Bihar, India |
| Medstry Biotech Private Limited | ₹53.49 Lakh (FY 2021) | •••• | •••• | 23.0% | •••• | Manimajra, Chandigarh, India |
| Veejay Med Point Private Limited | ₹53.42 Lakh (FY 2024) | •••• | •••• | 0.0% | •••• | Chennai, Tamil Nadu, India |
| Eka Essentials Pharma Private Limited | ₹53.42 Lakh (FY 2024) | •••• | •••• | -20.0% | •••• | Coimbatore, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Resonacle Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Resonacle Pharma Private Limited
Auditor information for Resonacle Pharma Private Limited provides details about the firm responsible for auditing the company's financial statements and ensuring compliance with regulatory requirements.
Board of Directors of Resonacle Pharma Private Limited
Resonacle Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jai Shree Panwar Also directs: Resonacle Securities and Staffing Services LLP | Manager | 26 Feb 2016 | 10 Years 7 Months | Current |
| Greejesh Kumar Singh Also directs: Lalvium International LLP | Director | 26 Feb 2016 | 10 Years 7 Months | Current |
Ownership and Shareholding of Resonacle Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Resonacle Pharma Private Limited
Resonacle Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Resonacle Pharma Private Limited
Resonacle Pharma operates two associated brands: Resonacle and Resonacle Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers recruitment services for pharma and chemical industries globally. | resonacle.com | |
| Export of pharmaceutical products and injectable medicines to global markets. | resonaclepharma.com |
Employees and EPFO Compliance at Resonacle Pharma Private Limited
Employment history and EPFO contributions of people linked to Resonacle Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Resonacle Pharma Private Limited
Resonacle Pharma Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Amit Shyammohan Saxena ceased to be Additional Director on 05 Oct 2021.
Credit Ratings, Litigation & Regulatory Alerts for Resonacle Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Resonacle Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Resonacle Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Resonacle Pharma Private Limited
Resonacle Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCR6497G1ZT | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Resonacle Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Resonacle Pharma Private Limited
Resonacle Pharma is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 February 2016 (10+ years old) and is registered under CIN U74900MH2016PTC273571.
Resonacle Pharma reported revenue of ₹53.73 Lakh for FY 2024.
Resonacle Pharma has 2 current directors:
- Greejesh Kumar Singh - Director
- Jai Shree Panwar - Manager
Resonacle Pharma reported a net profit of ₹4.81 Lakh (net margin 9%) and EBITDA of ₹6.22 Lakh (EBITDA margin 11.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Resonacle Pharma is 171% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Resonacle Pharma is 27AAHCR6497G1ZT, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Resonacle Pharma is U74900MH2016PTC273571. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Resonacle Pharma was incorporated on 26 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Resonacle Pharma by revenue are Sunbird Healthcare Private Limited, Xellence Laboratories Private Limited, Miles Healthcare Private Limited, Sanivo Biotec Private Limited, Hygieia Biogenics Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Amit Shyammohan Saxena ceased to be Additional Director on 05 Oct 2021. Greejesh Kumar Singh was appointed as Director on 26 Feb 2016. Jai Shree Panwar was appointed as Manager on 26 Feb 2016.
Resonacle Pharma can be reached through the website resonaclepharma.com. Its registered office is in Navi Mumbai, Maharashtra, India.